1
|
Danesin N, Bonaldi L, Martines A, Nalio S, Bertorelle R, Compagno S, Marcato R, Manni S, Scarmozzino F, Pizzi M, Tos APD, Cellini A, Scapinello G, Visentin A, Trentin L, Piazza F. Impact of the presence and number of chromosomal abnormalities on the clinical outcome in Waldenström Macroglobulinemia: a monocentric experience. Ann Hematol 2024:10.1007/s00277-024-05770-4. [PMID: 38687347 DOI: 10.1007/s00277-024-05770-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2024] [Accepted: 04/19/2024] [Indexed: 05/02/2024]
Abstract
The prognostic and predictive role of specific gene mutations in Waldenström Macroglobulinemia (WM) is well-ascertained whereas the clinical impact of chromosome aberrations is far less known. Recent work has provided initial evidence for an adverse prognostic impact of some aberrations, such as del(6q), while other studies suggest a possible relationship between some clinical features (e.g. advanced age and/or inflammatory status) and specific cytogenetic abnormalities. To add to the still limited knowledge on WM cytogenetics and its clinical implications, we herein report our experience in a cohort of WM patients across 23 years. Based on our retrospective study, we found that abnormal karyotype was more represented in older patients and maintained a statistically significant independence from other molecular, clinical, and biological features related to WM. The presence and number of cytogenetic aberrations correlated with inferior overall and progression-free survival outcomes regardless of the type of single chromosome aberration. Our data suggests that the role of the altered karyotype deserves to be further clarified especially in elderly WM patients, in whom cytogenetic abnormalities and disease biology appear to be characterized by a higher degree of complexity.
Collapse
Affiliation(s)
- Nicolò Danesin
- Hematology Unit, Department of Medicine, University of Padova, Via Giustiniani 2, 35128, Padua, Italy
| | - Laura Bonaldi
- Immunology and Molecular Oncology Diagnostics, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy
| | - Annalisa Martines
- Immunology and Molecular Oncology Diagnostics, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy
| | - Silvia Nalio
- Immunology and Molecular Oncology Diagnostics, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy
| | - Roberta Bertorelle
- Immunology and Molecular Oncology Diagnostics, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy
| | - Sofia Compagno
- Immunology and Molecular Oncology Diagnostics, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy
| | - Raffaella Marcato
- Immunology and Molecular Oncology Diagnostics, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy
| | - Sabrina Manni
- Hematology Unit, Department of Medicine, University of Padova, Via Giustiniani 2, 35128, Padua, Italy
- Veneto Institute of Molecular Medicine, Fondazione Per La Ricerca Biomedica Avanzata, Padua, Italy
| | - Federico Scarmozzino
- Surgical Pathology and Cytopathology Unit, Department of Medicine, University of Padova, Padua, Italy
| | - Marco Pizzi
- Surgical Pathology and Cytopathology Unit, Department of Medicine, University of Padova, Padua, Italy
| | - Angelo Paolo Dei Tos
- Surgical Pathology and Cytopathology Unit, Department of Medicine, University of Padova, Padua, Italy
| | - Alessandro Cellini
- Hematology Unit, Department of Medicine, University of Padova, Via Giustiniani 2, 35128, Padua, Italy
| | - Greta Scapinello
- Hematology Unit, Department of Medicine, University of Padova, Via Giustiniani 2, 35128, Padua, Italy
| | - Andrea Visentin
- Hematology Unit, Department of Medicine, University of Padova, Via Giustiniani 2, 35128, Padua, Italy
| | - Livio Trentin
- Hematology Unit, Department of Medicine, University of Padova, Via Giustiniani 2, 35128, Padua, Italy
| | - Francesco Piazza
- Hematology Unit, Department of Medicine, University of Padova, Via Giustiniani 2, 35128, Padua, Italy.
- Veneto Institute of Molecular Medicine, Fondazione Per La Ricerca Biomedica Avanzata, Padua, Italy.
| |
Collapse
|
2
|
Brambullo T, De Lazzari A, Franchi A, Trevisson E, Garau ML, Scarmozzino F, Vindigni V, Bassetto F. A Misdiagnosed Familiar Brooke-Spiegler Syndrome: Case Report and Review of the Literature. J Clin Med 2024; 13:2240. [PMID: 38673513 PMCID: PMC11050603 DOI: 10.3390/jcm13082240] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2024] [Revised: 03/21/2024] [Accepted: 04/08/2024] [Indexed: 04/28/2024] Open
Abstract
Aim of the report: Brooke-Spiegler syndrome (BSS) is a rare autosomal dominant disease characterized by the growth of cylindromas, spiradenomas, trichoepitheliomas, or their combination. These neoplasms usually begin in the second decade and progressively increase in number and size over the years. Diagnosis necessitates consideration of family history, clinical examination, histological findings, and genetic analysis. The aim of this paper is to explore the clinical overlap between Brooke-Spiegler syndrome (BSS) and neurofibromatosis type 1 (NF1). We aim to highlight the challenges associated with their differential diagnosis and emphasize the lack of standardized diagnostic criteria and treatment approaches. Case presentation: Hereby, we introduce the case of a 28-year-old male referred for suspicion of neurofibromatosis type 1 (NF1) who initially declined the recommended surgical excision for a scalp mass. After four years, he returned with larger masses of the scalp, and underwent excision of multiple masses, revealing cylindromas, spiradenomas, and spiradenocylindromas. Family history reported similar tumors in his father, who was also diagnosed with NF1 for the presence of multiple subcutaneous lesions on the scalp. Clinical overlap led to a genetic consultation, but testing for CYLD mutations yielded no significant variations. Despite this, the strong family history and consistent findings led to a revised diagnosis of Brooke-Spiegler syndrome, correcting the initial misdiagnosis of NF1 syndrome. Conclusions: Thanks to the evolving landscape of BSS research over the past two decades, its molecular underpinnings, clinical presentation, and histopathological features are now clearer. However, a thorough family history assessment is mandatory when BSS is suspected. It is our belief that a multidisciplinary approach and cooperation between specialists are essential when dealing with BSS. By sharing this case, we hope to underscore the importance of considering BSS as a differential diagnosis, especially in cases with atypical presentations or overlapping features with other syndromes like NF1.
Collapse
Affiliation(s)
- Tito Brambullo
- Clinic of Plastic Surgery, Neurosciences Department, University of Padua, 35131 Padua, Italy; (T.B.); (A.D.L.); (A.F.); (V.V.)
| | - Alberto De Lazzari
- Clinic of Plastic Surgery, Neurosciences Department, University of Padua, 35131 Padua, Italy; (T.B.); (A.D.L.); (A.F.); (V.V.)
| | - Arianna Franchi
- Clinic of Plastic Surgery, Neurosciences Department, University of Padua, 35131 Padua, Italy; (T.B.); (A.D.L.); (A.F.); (V.V.)
| | - Eva Trevisson
- Clinical Genetics Unit, Department of Women and Children’s Health, University of Padova, 35131 Padua, Italy; (E.T.); (M.L.G.)
| | - Maria Luisa Garau
- Clinical Genetics Unit, Department of Women and Children’s Health, University of Padova, 35131 Padua, Italy; (E.T.); (M.L.G.)
| | - Federico Scarmozzino
- Surgical Pathology & Cytopathology Unit, Department of Medicine (DIMED), University of Padova, 35131 Padova, Italy;
| | - Vincenzo Vindigni
- Clinic of Plastic Surgery, Neurosciences Department, University of Padua, 35131 Padua, Italy; (T.B.); (A.D.L.); (A.F.); (V.V.)
| | - Franco Bassetto
- Clinic of Plastic Surgery, Neurosciences Department, University of Padua, 35131 Padua, Italy; (T.B.); (A.D.L.); (A.F.); (V.V.)
| |
Collapse
|
3
|
Pizzi M, Bongiovanni L, Lorenzi L, Righi S, Scarmozzino F, Balzarini P, Santoro L, Mussolin L, Carraro E, Pillon M, Bonaldi L, Vianello F, Agostinelli C, Ponzoni M, Dei Tos AP, Sabattini E. Large B-cell lymphoma with IRF4 rearrangement: a multi-centric study with focus on potential misleading phenotypes. Virchows Arch 2024; 484:521-526. [PMID: 37962684 DOI: 10.1007/s00428-023-03689-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2023] [Revised: 10/22/2023] [Accepted: 10/24/2023] [Indexed: 11/15/2023]
Abstract
Large B-cell lymphoma with IRF4 rearrangement (LBCL-IRF4) is a rare lymphoid neoplasm, usually occurring in the pediatric/young-adult age. Despite this, subsets of cases occur in elderly patients and express CD5, possibly entering the differential diagnosis with adult aggressive lymphomas, such as blastoid/pleomorphic mantle cell lymphoma (MCL-B/P). To better characterize the clinical-pathological features and differential diagnosis of LBCL-IRF4, we conducted a multi-centric study on 12 cases, focusing on CD5, Cyclin D1, and SOX11 expression. While most cases had typical presentation, adult-to-elderly age at diagnosis and unusual anatomic locations were reported in 3/12 (25.0%) and 2/12 (16.7%) patients, respectively. Histologically, CD5 was positive in 4/12 (33.3%) cases, Cyclin D1 was invariably negative, and SOX11 was weakly/partially expressed in 1/12 (8.3%) case. In conclusion, LBCL-IRF4 can have unconventional clinical presentations that may challenge its recognition. Although CD5 is frequently expressed, negativity for Cyclin D1 and SOX11 contributes to the differential diagnosis with MCL-B/P.
Collapse
Affiliation(s)
- Marco Pizzi
- Surgical Pathology and Cytopathology Unit, Department of Medicine - DIMED, University of Padua School of Medicine, via A. Gabelli, 61, 35121, Padua, PD, Italy.
| | - Lucia Bongiovanni
- Haematopathology Diagnostic Area, Pathology Unit, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy
| | - Luisa Lorenzi
- Section of Pathology, Department of Molecular and Translational Medicine, University of Brescia School of Medicine, Spedali Civili di Brescia, Brescia, Italy
| | - Simona Righi
- Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy
- Hematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
| | - Federico Scarmozzino
- Surgical Pathology and Cytopathology Unit, Department of Medicine - DIMED, University of Padua School of Medicine, via A. Gabelli, 61, 35121, Padua, PD, Italy
| | - Piera Balzarini
- Section of Pathology, Department of Molecular and Translational Medicine, University of Brescia School of Medicine, Spedali Civili di Brescia, Brescia, Italy
| | - Luisa Santoro
- Surgical Pathology and Cytopathology Unit, Department of Medicine - DIMED, University of Padua School of Medicine, via A. Gabelli, 61, 35121, Padua, PD, Italy
| | - Lara Mussolin
- Oncohematology Unit, Maternal and Child Health Department, Pediatric Hematology, Oncology and Stem Cell Transplant Center, University of Padua School of Medicine, Padua, Italy
| | - Elisa Carraro
- Oncohematology Unit, Maternal and Child Health Department, Pediatric Hematology, Oncology and Stem Cell Transplant Center, University of Padua School of Medicine, Padua, Italy
| | - Marta Pillon
- Oncohematology Unit, Maternal and Child Health Department, Pediatric Hematology, Oncology and Stem Cell Transplant Center, University of Padua School of Medicine, Padua, Italy
| | - Laura Bonaldi
- Immunology and Molecular Oncology Unit, IRCSS Istituto Oncologico Veneto, Padua, Italy
| | - Fabrizio Vianello
- Hematology and Clinical Immunology Unit, Department of Medicine - DIMED, University of Padua School of Medicine, Padua, Italy
| | - Claudio Agostinelli
- Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy
- Hematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
| | - Maurilio Ponzoni
- Haematopathology Diagnostic Area, Pathology Unit, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy
| | - Angelo Paolo Dei Tos
- Surgical Pathology and Cytopathology Unit, Department of Medicine - DIMED, University of Padua School of Medicine, via A. Gabelli, 61, 35121, Padua, PD, Italy
| | - Elena Sabattini
- Hematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
| |
Collapse
|
4
|
Pizzi M, Bongiovanni L, Lorenzi L, Righi S, Scarmozzino F, Balzarini P, Santoro L, Mussolin L, Carraro E, Pillon M, Bonaldi L, Vianello F, Agostinelli C, Ponzoni M, Dei Tos AP, Sabattini E. Correction to: Large B-cell lymphoma with IRF4 rearrangement: a multi-centric study with focus on potential misleading phenotypes. Virchows Arch 2024; 484:549. [PMID: 38289502 DOI: 10.1007/s00428-024-03751-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2024]
Affiliation(s)
- Marco Pizzi
- Surgical Pathology and Cytopathology Unit, Department of Medicine - DIMED, University of Padua School of Medicine, via A. Gabelli, 61, 35121, Padua, PD, Italy.
| | - Lucia Bongiovanni
- Haematopathology Diagnostic Area, Pathology Unit, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy
| | - Luisa Lorenzi
- Section of Pathology, Department of Molecular and Translational Medicine, University of Brescia School of Medicine, Spedali Civili di Brescia, Brescia, Italy
| | - Simona Righi
- Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy
- Hematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
| | - Federico Scarmozzino
- Surgical Pathology and Cytopathology Unit, Department of Medicine - DIMED, University of Padua School of Medicine, via A. Gabelli, 61, 35121, Padua, PD, Italy
| | - Piera Balzarini
- Section of Pathology, Department of Molecular and Translational Medicine, University of Brescia School of Medicine, Spedali Civili di Brescia, Brescia, Italy
| | - Luisa Santoro
- Surgical Pathology and Cytopathology Unit, Department of Medicine - DIMED, University of Padua School of Medicine, via A. Gabelli, 61, 35121, Padua, PD, Italy
| | - Lara Mussolin
- Oncohematology Unit, Maternal and Child Health Department, Pediatric Hematology, Oncology and Stem Cell Transplant Center, University of Padua School of Medicine, Padua, Italy
| | - Elisa Carraro
- Oncohematology Unit, Maternal and Child Health Department, Pediatric Hematology, Oncology and Stem Cell Transplant Center, University of Padua School of Medicine, Padua, Italy
| | - Marta Pillon
- Oncohematology Unit, Maternal and Child Health Department, Pediatric Hematology, Oncology and Stem Cell Transplant Center, University of Padua School of Medicine, Padua, Italy
| | - Laura Bonaldi
- Immunology and Molecular Oncology Unit, IRCCS Istituto Oncologico Veneto, Padua, Italy
| | - Fabrizio Vianello
- Hematology and Clinical Immunology Unit, Department of Medicine - DIMED, University of Padua School of Medicine, Padua, Italy
| | - Claudio Agostinelli
- Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy
- Hematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
| | - Maurilio Ponzoni
- Haematopathology Diagnostic Area, Pathology Unit, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy
| | - Angelo Paolo Dei Tos
- Surgical Pathology and Cytopathology Unit, Department of Medicine - DIMED, University of Padua School of Medicine, via A. Gabelli, 61, 35121, Padua, PD, Italy
| | - Elena Sabattini
- Hematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
| |
Collapse
|
5
|
Scarmozzino F, Pizzi M, Pelizzaro F, Angerilli V, Dei Tos AP, Piazza F, Savarino EV, Zingone F, Fassan M. Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges. Front Oncol 2023; 13:1273305. [PMID: 38023263 PMCID: PMC10662059 DOI: 10.3389/fonc.2023.1273305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2023] [Accepted: 10/20/2023] [Indexed: 12/01/2023] Open
Abstract
Refractory celiac disease (RCD) and enteropathy-associated T-cell lymphoma (EATL) are rare, yet severe complications of celiac disease (CD). Over the last decades, several studies have addressed the biology and clinical-pathological features of such conditions, highlighting unique disease patterns and recurrent genetic events. Current classification proposals identify two forms of RCD, namely: (i) type 1 RCD (RCD-I), characterized by phenotypically normal intra-epithelial lymphocytes (IELs); and (ii) type 2 RCD (RCD-II), featuring phenotypically aberrant IELs. While RCD-I likely represents a gluten-independent dysimmune reaction against small bowel epithelial cells, RCD-II is better considered an in situ aggressive T-cell lymphoma, with high rates of progression to overt EATL. The diagnosis of RCD and EATL is often challenging, due to misleading clinical-pathological features and to significant overlap with several CD-unrelated gastro-intestinal disorders. Similarly, the treatment of RCD and EATL is an unmet clinical need for both gastroenterologists and hematologists. Moving from such premises, this review aims to provide a comprehensive view of RCD and EATL, specifically considering their pathogenesis and the many still open issues concerning their diagnosis and clinical management.
Collapse
Affiliation(s)
- Federico Scarmozzino
- Surgical Pathology and Cytopathology Unit, Department of Medicine-DIMED, University of Padua School of Medicine, Padua, Italy
| | - Marco Pizzi
- Surgical Pathology and Cytopathology Unit, Department of Medicine-DIMED, University of Padua School of Medicine, Padua, Italy
| | - Filippo Pelizzaro
- Gastroenterology Unit, Department of Surgical, Gastroenterological and Oncological Sciences -DISCOG, University of Padua School of Medicine, Padua, Italy
| | - Valentina Angerilli
- Surgical Pathology and Cytopathology Unit, Department of Medicine-DIMED, University of Padua School of Medicine, Padua, Italy
| | - Angelo Paolo Dei Tos
- Surgical Pathology and Cytopathology Unit, Department of Medicine-DIMED, University of Padua School of Medicine, Padua, Italy
| | - Francesco Piazza
- Hematology & Clinical Immunology Unit, Department of Medicine-DIMED, University of Padua School of Medicine, Padua, Italy
| | - Edoardo Vincenzo Savarino
- Gastroenterology Unit, Department of Surgical, Gastroenterological and Oncological Sciences -DISCOG, University of Padua School of Medicine, Padua, Italy
| | - Fabiana Zingone
- Gastroenterology Unit, Department of Surgical, Gastroenterological and Oncological Sciences -DISCOG, University of Padua School of Medicine, Padua, Italy
| | - Matteo Fassan
- Surgical Pathology and Cytopathology Unit, Department of Medicine-DIMED, University of Padua School of Medicine, Padua, Italy
- Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy
| |
Collapse
|
6
|
Cellini A, Scarmozzino F, Angotzi F, Ruggeri E, Dei Tos AP, Trentin L, Pizzi M, Visentin A. Tackling the dysregulated immune-checkpoints in classical Hodgkin lymphoma: bidirectional regulations between the microenvironment and Hodgkin/Reed-Sternberg cells. Front Oncol 2023; 13:1203470. [PMID: 37293587 PMCID: PMC10244642 DOI: 10.3389/fonc.2023.1203470] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2023] [Accepted: 05/12/2023] [Indexed: 06/10/2023] Open
Abstract
Immune evasion is considered one of the modern hallmarks of cancer and is a key element in the pathogenesis of classical Hodgkin Lymphoma (cHL). This haematological cancer achieves effective avoidance of the host's immune system by overexpressing the PD-L1 and PD-L2 proteins on the surface of the neoplastic cells. Subversion of the PD-1/PD-L axis, however, is not the sole contributor to immune evasion in cHL, as the microenvironment nurtured by the Hodgkin/Reed-Sternberg cells is a major player in the creation of a biological niche that sustains their survival and hinders immune recognition. In this review, we will discuss the physiology of the PD-1/PD-L axis and how cHL is able to exploit a plethora of different molecular mechanisms to build an immunosuppressive microenvironment and achieve optimal immune evasion. We will then discuss the success obtained by checkpoint inhibitors (CPI) in treating cHL, both as single agents and as part of combination strategies, analysing the rationale for their combination with traditional chemotherapeutic compounds and the proposed mechanisms of resistance to CPI immunotherapy.
Collapse
Affiliation(s)
- Alessandro Cellini
- Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy
| | - Federico Scarmozzino
- Surgical Pathology and Cytopathology Unit, Department of Medicine, University of Padua, Padua, Italy
| | - Francesco Angotzi
- Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy
| | - Edoardo Ruggeri
- Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy
| | - Angelo Paolo Dei Tos
- Surgical Pathology and Cytopathology Unit, Department of Medicine, University of Padua, Padua, Italy
| | - Livio Trentin
- Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy
| | - Marco Pizzi
- Surgical Pathology and Cytopathology Unit, Department of Medicine, University of Padua, Padua, Italy
| | - Andrea Visentin
- Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy
| |
Collapse
|
7
|
Pizzi M, Vianello F, Lorenzi L, Binotto G, Sbaraglia M, Scarmozzino F, De Crescenzo A, Guzzardo V, Zoletto S, d'Amore F, Friziero A, D'Adda M, Facchetti F, Dei Tos AP. Accessory spleens recapitulate the immune microenvironment of the main spleen in immune thrombocytopenia. Br J Haematol 2023. [PMID: 36916680 DOI: 10.1111/bjh.18749] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2022] [Revised: 02/26/2023] [Accepted: 02/27/2023] [Indexed: 03/15/2023]
Abstract
Accessory spleens (AcS) may play a relevant role in immune thrombocytopenia (ITP) and possibly contribute to ITP relapse following splenectomy. Little is known about the immune microenvironment of AcS in ITP. To address this issue, we compared the histological features of eight matched AcS and main spleen (MS) samples, obtained from adult patients with primary ITP. AcS and MS had overlapping immune architectural features and lymphoid composition, suggesting that similar immunologic events occur in AcS and MS of ITP. These findings may have implications for the potential mechanisms of AcS-mediated ITP relapse. Further studies are needed to confirm these results and to dissect spleen immunity in ITP.
Collapse
Affiliation(s)
- Marco Pizzi
- Surgical Pathology and Cytopathology Unit, Department of Medicine-DIMED, University of Padua School of Medicine, Padua, Italy
| | - Fabrizio Vianello
- Haematology & Clinical Immunology Unit, Department of Medicine-DIMED, University of Padua School of Medicine, Padua, Italy
| | - Luisa Lorenzi
- Section of Pathology, Department of Molecular and Translational Medicine, University of Brescia School of Medicine, Spedali Civili di Brescia, Brescia, Italy
| | - Gianni Binotto
- Haematology & Clinical Immunology Unit, Department of Medicine-DIMED, University of Padua School of Medicine, Padua, Italy
| | - Marta Sbaraglia
- Surgical Pathology and Cytopathology Unit, Department of Medicine-DIMED, University of Padua School of Medicine, Padua, Italy
| | - Federico Scarmozzino
- Surgical Pathology and Cytopathology Unit, Department of Medicine-DIMED, University of Padua School of Medicine, Padua, Italy
| | - Andrea De Crescenzo
- Haematology & Clinical Immunology Unit, Department of Medicine-DIMED, University of Padua School of Medicine, Padua, Italy
| | - Vincenza Guzzardo
- Surgical Pathology and Cytopathology Unit, Department of Medicine-DIMED, University of Padua School of Medicine, Padua, Italy
| | - Simone Zoletto
- Haematology & Clinical Immunology Unit, Department of Medicine-DIMED, University of Padua School of Medicine, Padua, Italy
| | - Fabio d'Amore
- Haematology & Clinical Immunology Unit, Department of Medicine-DIMED, University of Padua School of Medicine, Padua, Italy
| | - Alberto Friziero
- 1st Surgical Clinic, Department of Surgical Oncological and Gastroenterological Sciences, University of Padua School of Medicine, Padua, Italy
| | - Mariella D'Adda
- Haematology Unit, ASST Spedali Civili di Brescia, Brescia, Italy
| | - Fabio Facchetti
- Section of Pathology, Department of Molecular and Translational Medicine, University of Brescia School of Medicine, Spedali Civili di Brescia, Brescia, Italy
| | - Angelo Paolo Dei Tos
- Surgical Pathology and Cytopathology Unit, Department of Medicine-DIMED, University of Padua School of Medicine, Padua, Italy
| |
Collapse
|
8
|
Pizzi M, Sbaraglia M, Dal Santo L, De Bartolo D, Santoro L, Scarmozzino F, Mussolin L, Pillon M, Piazza F, Trentin L, Dei Tos AP. Higher accuracy of surgical over core needle biopsy for the diagnosis of lymphoproliferative disorders. Int J Lab Hematol 2023. [PMID: 36871956 DOI: 10.1111/ijlh.14055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2022] [Accepted: 02/17/2023] [Indexed: 03/07/2023]
Abstract
INTRODUCTION The diagnosis of lymphoproliferative disorders (LPDs) is based on histological evaluation of representative tissue samples. Despite surgical excision biopsies (SEBs) are reference procedures for such diagnoses, lymph node core needle biopsies (LNCBs) are increasingly performed. The diagnostic yield of LNCB is, however, debated and few studies have compared the reproducibility of LNCB and SEB findings. METHODS To address the diagnostic value of LNCB and SEB, the present study considered a retrospective series of 43 paired LNCB/SEB samples. After histological revision, concordance rates between matched LNCB/SEB samples were evaluated, assuming SEB as gold standard procedure. The actionability of LNCB and SEB-based diagnoses (i.e., relevance for planning further medical interventions) was also assessed. RESULTS Overall, LNCB provided actionable diagnoses in 39/43 (90.7%) cases, but a consistent subset of them (7/39 [17.9%]) turned out to be wrong at SEB. The cumulative diagnostic inaccuracy of LNCB (i.e., inadequate samples plus wrong diagnoses) was 25.6% and the mean diagnostic delay in such cases was 54.2 days. CONCLUSIONS Although limited by selection biases due to its retrospective nature, this study highlights the intrinsic limitations of LNCB for the diagnosis of LPDs. SEB remains the gold standard procedure and should be performed in all suitable cases.
Collapse
Affiliation(s)
- Marco Pizzi
- Surgical Pathology and Cytopathology Unit, Department of Medicine-DIMED, University of Padua School of Medicine, Padua, Italy
| | - Marta Sbaraglia
- Surgical Pathology and Cytopathology Unit, Department of Medicine-DIMED, University of Padua School of Medicine, Padua, Italy
| | - Luca Dal Santo
- Surgical Pathology and Cytopathology Unit, Department of Medicine-DIMED, University of Padua School of Medicine, Padua, Italy
| | - Debora De Bartolo
- Surgical Pathology and Cytopathology Unit, Department of Medicine-DIMED, University of Padua School of Medicine, Padua, Italy
| | - Luisa Santoro
- Surgical Pathology and Cytopathology Unit, Department of Medicine-DIMED, University of Padua School of Medicine, Padua, Italy
| | - Federico Scarmozzino
- Surgical Pathology and Cytopathology Unit, Department of Medicine-DIMED, University of Padua School of Medicine, Padua, Italy
| | - Lara Mussolin
- Oncohematology Unit, Department of Children and Women's Health, University of Padua School of Medicine, Padua, Italy
| | - Marta Pillon
- Oncohematology Unit, Department of Children and Women's Health, University of Padua School of Medicine, Padua, Italy
| | - Francesco Piazza
- Hematology & Clinical Immunology Unit, Department of Medicine-DIMED, University of Padua School of Medicine, Padua, Italy
| | - Livio Trentin
- Hematology & Clinical Immunology Unit, Department of Medicine-DIMED, University of Padua School of Medicine, Padua, Italy
| | - Angelo Paolo Dei Tos
- Surgical Pathology and Cytopathology Unit, Department of Medicine-DIMED, University of Padua School of Medicine, Padua, Italy
| |
Collapse
|
9
|
Cellini A, Scarmozzino F, Friziero A, Trimarco V, Dei Tos AP, Trentin L, Pizzi M, Visentin A. Persistent splenomegaly due to littoral cell angiomatosis in venetoclax-induced undetectable minimal residual disease of chronic lymphocytic leukemia. Ann Hematol 2023; 102:681-682. [PMID: 36542103 DOI: 10.1007/s00277-022-05067-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2022] [Accepted: 12/01/2022] [Indexed: 12/24/2022]
Affiliation(s)
- Alessandro Cellini
- Hematology and Clinical Immunology Unit, Department of Medicine - DIMED, University of Padua, Padua, Italy
| | - Federico Scarmozzino
- Surgical Pathology and Cytopathology Units, Department of Medicine - DIMED, University of Padua, Padua, Italy
| | - Alberto Friziero
- 1St General Surgery Unit, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy
| | - Valentina Trimarco
- Hematology and Clinical Immunology Unit, Department of Medicine - DIMED, University of Padua, Padua, Italy
| | - Angelo Paolo Dei Tos
- Surgical Pathology and Cytopathology Units, Department of Medicine - DIMED, University of Padua, Padua, Italy
| | - Livio Trentin
- Hematology and Clinical Immunology Unit, Department of Medicine - DIMED, University of Padua, Padua, Italy
| | - Marco Pizzi
- Surgical Pathology and Cytopathology Units, Department of Medicine - DIMED, University of Padua, Padua, Italy.
- Surgical Pathology and Cytopathology Units, Department of Medicine, University of Padua School of Medicine, Via Giustiniani, 2, 35128, Padua, Italy.
| | - Andrea Visentin
- Hematology and Clinical Immunology Unit, Department of Medicine - DIMED, University of Padua, Padua, Italy
| |
Collapse
|
10
|
Pizzi M, Vianello F, Binotto G, Vianelli N, Carli G, Auteri G, Nichele I, Sbaraglia M, Zoletto S, Scarmozzino F, Bresciani R, d'Amore F, Friziero A, Guzzardo V, Bertozzi I, Famengo B, d'Amore ESG, Sabattini E, Dei Tos AP. Thrombopoietin receptor agonists increase splenic regulatory T‐cell numbers in immune thrombocytopenia. Br J Haematol 2022; 198:916-922. [DOI: 10.1111/bjh.18309] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2022] [Revised: 05/18/2022] [Accepted: 06/01/2022] [Indexed: 01/26/2023]
Affiliation(s)
- Marco Pizzi
- Surgical Pathology and Cytopathology Unit, Department of Medicine‐DIMED University of Padua School of Medicine Padua Italy
| | - Fabrizio Vianello
- Hematology and Clinical Immunology Unit, Department of Medicine‐DIMED University of Padua School of Medicine Padua Italy
| | - Gianni Binotto
- Hematology and Clinical Immunology Unit, Department of Medicine‐DIMED University of Padua School of Medicine Padua Italy
| | - Nicola Vianelli
- IRCCS Azienda Ospedaliero‐Universitaria di Bologna Istituto di Ematologia "Seràgnoli" Bologna Italy
| | - Giuseppe Carli
- Hematology Unit Azienda ULSS 8 Berica ‐ San Bortolo Hospital Vicenza Italy
| | - Giuseppe Auteri
- IRCCS Azienda Ospedaliero‐Universitaria di Bologna Istituto di Ematologia "Seràgnoli" Bologna Italy
- Dipartimento di Medicina Specialistica Diagnostica e Sperimentale University of Bologna Bologna Italy
| | - Ilaria Nichele
- Hematology Unit Azienda ULSS 8 Berica ‐ San Bortolo Hospital Vicenza Italy
| | - Marta Sbaraglia
- Surgical Pathology and Cytopathology Unit, Department of Medicine‐DIMED University of Padua School of Medicine Padua Italy
| | - Simone Zoletto
- Hematology and Clinical Immunology Unit, Department of Medicine‐DIMED University of Padua School of Medicine Padua Italy
| | - Federico Scarmozzino
- Surgical Pathology and Cytopathology Unit, Department of Medicine‐DIMED University of Padua School of Medicine Padua Italy
| | - Rita Bresciani
- Surgical Pathology and Cytopathology Unit, Department of Medicine‐DIMED University of Padua School of Medicine Padua Italy
| | - Fabio d'Amore
- Hematology and Clinical Immunology Unit, Department of Medicine‐DIMED University of Padua School of Medicine Padua Italy
| | - Alberto Friziero
- 1st General Surgery Unit, Department of Surgery, Oncology and Gastroenterology University of Padova School of Medicine Padova Italy
| | - Vincenza Guzzardo
- Surgical Pathology and Cytopathology Unit, Department of Medicine‐DIMED University of Padua School of Medicine Padua Italy
| | - Irene Bertozzi
- 1st Medical Clinic, Department of Medicine – DIMED University of Padua School of Medicine Padua Italy
| | - Barbara Famengo
- Department of Pathological Anatomy Azienda ULSS 8 Berica ‐ San Bortolo Hospital Vicenza Italy
| | - Emanuele S. G. d'Amore
- Department of Pathological Anatomy Azienda ULSS 8 Berica ‐ San Bortolo Hospital Vicenza Italy
| | - Elena Sabattini
- Haemolymphopathology Unit IRCCS ‐ Azienda Ospedaliero‐Universitaria di Bologna Bologna Italy
| | - Angelo Paolo Dei Tos
- Surgical Pathology and Cytopathology Unit, Department of Medicine‐DIMED University of Padua School of Medicine Padua Italy
| |
Collapse
|
11
|
Scarmozzino F, Poli A, Visioli F. Microbiota and cardiovascular disease risk: A scoping review. Pharmacol Res 2020; 159:104952. [DOI: 10.1016/j.phrs.2020.104952] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/12/2020] [Revised: 05/20/2020] [Accepted: 05/20/2020] [Indexed: 02/08/2023]
|